Navigation Links
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
Date:1/22/2009

WHITE PLAINS, N.Y. and PRINCETON, N.J., Jan. 22 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Celator Pharmaceuticals, Inc. today announced a partnership to support Phase 2 development of Celator's lead product candidate CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for treatment of adults with acute myeloid leukemia (AML).

Through the partnership, LLS will provide $3.7 million to support Celator's Phase 2B multicenter, randomized, open-label trial of CPX-351 versus intensive salvage therapy in adult patients less than or equal to 60 years of age with AML in first relapse. Celator expects to start patient enrollment in this study in the first quarter of 2009 in the United States and Canada.

The partnership between Celator and LLS is part of LLS's Therapy Acceleration Program (TAP), which supports private sector and academic-based projects with the goal of advancing investigational therapies with high prospects for providing near-term benefit to patients with blood cancers.

"Celator has discovered a novel way to deliver and enhance the activity of agents that have been the standard of care in AML for decades," said Louis DeGennaro, Ph.D., LLS's chief scientific officer. "There have been many attempts to improve outcomes in this patient population with little success. The data collected on CPX-351 to date, and the enthusiasm of clinical investigators involved in that research, suggest that Celator's approach holds real promise to advance the treatment of AML."

"We are very pleased that The Leukemia & Lymphoma Society sees the potential of CPX-351 and is making this substantial investment," said Scott Jackson, chief executive officer, Celator Pharmaceuticals. "LLS has created a well defined, streamlined process for accessing capital for promising new blood cancer treatments. This commitment enhances our ability to further the clinical development of CPX-351
'/>"/>

SOURCE Celator Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Leukemia Drug Proves Safe and Effective Over the Long Term
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... Va. , Jan. 14, 2014 Animal Emergency Critical Care, ... Leesburg, Virginia is the first in ... oxygen chamber. Dr. Susan M. Barnes , ... Dr. Barnes and husband, Dr. Cole Taylor , are avid ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:ATS Medical Announces Fourth Quarter and Full Year 2009 Results 2ATS Medical Announces Fourth Quarter and Full Year 2009 Results 3ATS Medical Announces Fourth Quarter and Full Year 2009 Results 4ATS Medical Announces Fourth Quarter and Full Year 2009 Results 5ATS Medical Announces Fourth Quarter and Full Year 2009 Results 6ATS Medical Announces Fourth Quarter and Full Year 2009 Results 7ATS Medical Announces Fourth Quarter and Full Year 2009 Results 8ATS Medical Announces Fourth Quarter and Full Year 2009 Results 9ATS Medical Announces Fourth Quarter and Full Year 2009 Results 10ATS Medical Announces Fourth Quarter and Full Year 2009 Results 11ATS Medical Announces Fourth Quarter and Full Year 2009 Results 12ATS Medical Announces Fourth Quarter and Full Year 2009 Results 13ATS Medical Announces Fourth Quarter and Full Year 2009 Results 14ATS Medical Announces Fourth Quarter and Full Year 2009 Results 15ATS Medical Announces Fourth Quarter and Full Year 2009 Results 16ATS Medical Announces Fourth Quarter and Full Year 2009 Results 17ATS Medical Announces Fourth Quarter and Full Year 2009 Results 18ATS Medical Announces Fourth Quarter and Full Year 2009 Results 19ATS Medical Announces Fourth Quarter and Full Year 2009 Results 20ATS Medical Announces Fourth Quarter and Full Year 2009 Results 21WorldHeart Reports 2009 Financial Results 2WorldHeart Reports 2009 Financial Results 3WorldHeart Reports 2009 Financial Results 4WorldHeart Reports 2009 Financial Results 5WorldHeart Reports 2009 Financial Results 6WorldHeart Reports 2009 Financial Results 7WorldHeart Reports 2009 Financial Results 8
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... less than 40 years away from a food shortage ... according to a top scientist at the U.S. Agency ... history, food production will be limited on a global ... said Dr. Fred Davies, senior science advisor for the ... as politically destabilizing by 2050 as energy issues are ...
(Date:4/17/2014)... whose work has transformed cancer care in Northern Ireland, ... Academy of Cancer Sciences., The Academy, which was launched ... distinguished oncologists and cancer researchers which aims to reduce ... , Professor Johnston, whose leadership has seen cancer survival ... the UK league table to near the top, has ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Food shortages could be most critical world issue by mid-century 2
... Society for Radiation Oncology (ASTRO), the Association of Residents ... the 2011 Educator of the Year Award. , ARRO ... recognize outstanding teachers and mentors of radiation oncology residents. ... opportunity to select one faculty member from their program ...
... UCLA,s Jonsson Comprehensive Cancer Center have developed and ... and characterizes chemical compounds that can target the ... brain tumors. Glioblastoma is one of the ... 18 months. These brain cancers consist of two ...
... , MONDAY, Oct. 10 (HealthDay News) -- In the latest ... food, Swedish scientists report that eating chocolate seems to lower ... that women who had the highest consumption of chocolate -- ... percent reduced risk of stroke. "Cocoa contains flavonoids, which ...
... mother,s womb between the father,s biological goal to produce the ... through delivery might help explain preeclampsia, an often deadly disease ... yet small enough to pass through the birth canal. In ... these conflicting goals in balance. , The findings are ...
... Legs Syndrome, you may have a higher risk of developing ... Hypertension: Journal of the American Heart Association . RLS ... intense, unpleasant leg sensations, and an irresistible urge to move ... daytime drowsiness. It affects as many as 15 percent of ...
... it is a small study and more clinical trials ... result in a reduction in brain amyloid levels in ... Online First by Archives of Neurology , one ... suggests that the accumulation of amyloid-β (Aβ) peptides in ...
Cached Medicine News:Health News:ARRO honors 39 with Educator of the Year Award 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 3Health News:Chocolate Could Be Sweet Defense Against Stroke 2Health News:Chocolate Could Be Sweet Defense Against Stroke 3Health News:Battle between the placenta and uterus could help explain preeclampsia 2Health News:Restless legs syndrome may raise high blood pressure risk in middle-aged women 2Health News:Small study shows association between medication and reduction in brain amyloid levels related to AD 2
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Medicine Products: